Healthcare & Life Sciences

Astrocyte

series-a
series-a
Stage
2
Investors

About

Astrocyte develops small-molecule cerebroprotectants aimed at treating concussion, traumatic brain injury, and stroke.

Explore Astrocyte's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.